Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2023; 48(1): 7-11


Problem of antibiotic resistance in urinary tract infection in ALdiwaniyah city, Iraq

Vian Hussam Almansi Alqani, Mudhfar Mohammed Meizel, Anmar Hameed Habeeb ALfuadi.




Abstract

Objective: To identify the most common UTI-causing bacteria in the study samples and to identify the most culture-sensitive antibiotics.
Methodology: The study was conducted at Adiwahiyah Teaching Hospital in Iraq's mid-Euphrates area from January 15, 2018 to September 2, 2019. The research included 400 Iraqi patients ages 2 to 85 with UTI symptoms.
Results: E. coli was sensitive to imipenem, meropenem, amikacin, and chloramphenicol. Klebsiella pneumoneae was sensitive to amikacin, imipenem, and meropenem. Enterobacter aerogenes was sensitive to imipenem, chloramphenicol, amikacin, and meropenem. Morganella morganii was sensitive to imipenem, meropenem, amikacin, and chloramphenicol. Trimethoprim-sulphamethoxazole, trimethoprim, tetracycline, and doxycycline were effective against Proteus mirabilis. Imipenem and meropenem were effective against Pantoea agglomerans. Amikacin, imipenem, and meropenem were effective against Providencia stuartii. Serratia marcescens was susceptible to trimethoprim-sulphamethoxazole, trimethoprim, amikacin, chloramphenicol, imipenem, and meropenem.
Conclusion: In the current study, in order of frequency, the most frequently isolated bacteria were E. coli, followed by Staph aureus. The study showed that the three best antibiotics for almost all isolated bacteria were imipenem, meropenem and amikacin with very minor exceptions.

Key words: Antibiotic resistance, urinary tract infection, UTI, Iraq.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.